HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The long non-coding RNA HOTAIR is overexpressed in many cancers, promoting tumor growth and resistance. HOTAIR shows potential for early cancer detection, outcome prediction, and guiding therapy selection.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Long non-coding RNA HOTAIR is frequently overexpressed in various human cancers.
- HOTAIR contributes to cancer progression, including enhanced proliferation, migration, and treatment resistance.
Purpose Of The Study
- To comprehensively review research on HOTAIR in human cancers.
- To summarize molecular mechanisms, clinical significance, and therapeutic applications of HOTAIR.
Main Methods
- Literature review of studies on HOTAIR in cancer.
- Analysis of molecular mechanisms and clinical correlations.
- Discussion of therapeutic strategies involving HOTAIR.
Main Results
- HOTAIR overexpression correlates with tumor stage, metastasis, and survival.
- HOTAIR is implicated in cell proliferation, migration, and resistance to cancer treatments.
- HOTAIR serves as a potential biomarker for early detection and prognosis.
Conclusions
- HOTAIR is a significant factor in cancer development and progression.
- HOTAIR holds promise as a biomarker and therapeutic target in oncology.
- Further research into HOTAIR applications may advance cancer diagnostics and treatment.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...